4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-011338
Chief Medical Officer sold 8,009 shares at an average $31.69 ($253,780)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2022-02-16 | Option exercise | +5,000 | $1.53 | $7,650 | 97,777 | D |
| Pang Phillip Chief Medical Officer | 2022-02-16 | Sale | −5,000 | $31.54 | $157,700 | 92,777 | D |
| Pang Phillip Chief Medical Officer | 2022-02-17 | Sale | −3,009 | $31.93 | $96,080 | 89,768 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2022-02-16 | Option exercise · Stock Option (Right to Buy) | −5,000 | 52,591 | D | ||
| Open-market sales · 8,009 sh · avg $31.69 · $253,780 | |||||||
Loading xslF345X03/doc4.xml…